Starr International Co. Inc. Purchases Shares of 918 ICU Medical, Incorporated (NASDAQ:ICUI)

Starr International Co. Inc. acquired a new stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 918 shares of the medical instruments supplier’s stock, valued at approximately $220,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Advisory Services Network LLC lifted its holdings in shares of ICU Medical by 475.0% during the fourth quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 95 shares during the last quarter. We Are One Seven LLC purchased a new stake in shares of ICU Medical during the fourth quarter valued at $32,000. Berman Capital Advisors LLC purchased a new stake in shares of ICU Medical during the fourth quarter valued at $33,000. CX Institutional purchased a new stake in shares of ICU Medical during the first quarter valued at $34,000. Finally, Financial Gravity Companies Inc. purchased a new stake in shares of ICU Medical during the fourth quarter valued at $45,000. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently issued reports on ICUI shares. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, February 20th. Raymond James reduced their price objective on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research note on Friday, March 1st. TheStreet raised ICU Medical from a “c+” rating to a “b” rating in a research note on Friday, May 10th. Finally, Zacks Investment Research downgraded ICU Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Three investment analysts have rated the stock with a hold rating and one has issued a strong buy rating to the company. ICU Medical presently has an average rating of “Buy” and a consensus price target of $281.00.

In related news, COO Christian B. Voigtlander sold 5,348 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $227.59, for a total transaction of $1,217,151.32. Following the completion of the transaction, the chief operating officer now owns 4,732 shares in the company, valued at approximately $1,076,955.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert S. Swinney sold 229 shares of ICU Medical stock in a transaction on Friday, April 12th. The shares were sold at an average price of $231.43, for a total value of $52,997.47. Following the completion of the sale, the director now directly owns 18,076 shares of the company’s stock, valued at $4,183,328.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,318 shares of company stock worth $2,839,576. 11.40% of the stock is currently owned by insiders.

ICUI stock traded up $1.16 during mid-day trading on Friday, hitting $225.66. The stock had a trading volume of 105,921 shares, compared to its average volume of 187,412. ICU Medical, Incorporated has a 1-year low of $210.94 and a 1-year high of $321.70. The firm has a market cap of $4.66 billion, a P/E ratio of 29.27 and a beta of 0.69.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, beating the Zacks’ consensus estimate of $1.96 by $0.39. The business had revenue of $330.93 million for the quarter, compared to analyst estimates of $318.97 million. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The firm’s revenue for the quarter was down 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.26 EPS. As a group, sell-side analysts forecast that ICU Medical, Incorporated will post 8.55 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Starr International Co. Inc. Purchases Shares of 918 ICU Medical, Incorporated (NASDAQ:ICUI)” was originally posted by Sundance Herald and is the sole property of of Sundance Herald. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://sundanceherald.com/2019/05/24/starr-international-co-inc-acquires-shares-of-918-icu-medical-incorporated-icui.html.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Featured Article: How to Invest in the Dividend Aristocrat Index

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply